COPAN Diagnostics Launching First Fully Automated Instrument for Preparing Pour Plate Total Viable Counts (TVCs) at IAFP 2017

Milky Way for Preparing Pour Plate Total Viable Counts TAMPA, Fla., July 10, 2017 /PRNewswire/ — The MilkyWay is heading to the Sunshine State. COPAN Diagnostics, Inc. will unveil MilkyWay, the first fully automated instrument for preparing pour plate total viable bacterial counts on liquid samples, at the International Association for Food Protection Annual Conference in Tampa, Florida today. The... Read more

Agilent Technologies Presents Early Career Professor Award to Dr. Gary Patti

Washington University in St. Louis Professor Recognized for Groundbreaking Work in Metabolomics SANTA CLARA, Calif., July 10, 2017 Agilent Technologies Inc. (NYSE: A) has named Dr. Gary J. Patti, as the recipient of the prestigious 2017 Agilent Early Career Professor Award. Dr. Patti, Associate Professor, Department of Chemistry in Arts & Sciences, Washington University in... Read more

GE Healthcare partners with Oritain to introduce independent test to confirm country of origin of fetal bovine serum

CHALFONT ST. GILES, UK and Auckland, NEW ZEALAND – 10 July 2017 – GE Healthcare and Oritain are today launching an independent test-based traceability program to authenticate the country of origin of Fetal Bovine Serum (FBS). FBS is a cell growth supplement used in the manufacturing of biopharmaceuticals and vaccines for human health and veterinary... Read more

Neogen develops fastest Listeria test with no enrichment

CONTACT: Ed Bradley, Vice President of Food Safety, Neogen Corporation, 517/372-9200 LANSING, Mich., July 10, 2017 — Neogen Corporation (NASDAQ: NEOG) has developed an innovative test that detects Listeria in environmental samples in under 60 minutes — without the need to enrich samples. Neogen’s new Listeria Right Now™ test system can detect all species of Listeria, including the pathogenic L. monocytogenes, in... Read more

Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience

Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience WARREN, N.J., July 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that it has entered into a two year nonexclusive supply agreement with PURE Bioscience... Read more

Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine

Basel, 10 July 2017 Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate... Read more

Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine

Basel, 10 July 2017 Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate... Read more

Sartorius mourns the loss of Arnold Picot

Long-term Supervisory Board Chairman passes away Goettingen, Germany, July 10, 2017 – The Chairman of the Supervisory Board of Sartorius AG, Professor Arnold Picot, Ph.D., died unexpectedly at age 72 on July 9, 2017. Arnold Picot, who as executor also administered Horst Sartorius’ estate, had served at the helm of the Supervisory Board of Sartorius... Read more